新华联合投资年报 2022

ANNUAL REPORT年報2022 GEM CHARACTERISTICS OF GEM OF THE STOCKEXCHANGE OF HONG KONG LIMITED (THE“EXCHANGE”) GEM GEMhas been positioned as a market designed toaccommodatesmall and mid-sized companies towhich a higher investment risk may be attached thanother companies listed on the Exchange. Prospectiveinvestorsshould be aware of the potential risksofinvesting in such companies and should makethedecision to invest only after due and carefulconsideration. GEMGEMGEM Given that the companies listed on GEM are generallysmalland mid-sized companies,there is a risk thatsecurities traded on GEM may be more susceptible tohigh market volatility than securities traded on the MainBoard and no assurance is given that there will be aliquid market in the securities traded on GEM. HongKong Exchanges and Clearing Limited and theExchange take no responsibility for the contents of this report,make no representation as to its accuracy or completenessand expressly disclaim any liability whatsoever for any losshowsoever arising from or in reliance upon the whole or anypart of the contents of this report. GEMGEM This report, for which the directors (the “Directors”) of ChinaUnited Venture Investment Limited (formerly known as GLORYMARKHI-TECH(HOLDINGS)LIMITED)(the“Company”,together with its subsidiaries, the “Group”) collectively andindividuallyaccept full responsibility,includes particularsgivenin compliance with the Rules Governing the Listingof Securities on GEM of the Exchange (the “GEM ListingRules”)for the purpose of giving information with regardto the Company. The Directors, having made all reasonableenquiries, confirm that to the best of their knowledge andbelief,the information contained in this report is accurateandcomplete in all material respects and not misleadingor deceptive, and there are no other matters the omissionofwhich would make any statement herein or this reportmisleading. Contents Pages CORPORATE INFORMATION CHAIRMAN’S STATEMENT MANAGEMENT DISCUSSION AND ANALYSIS10 BIOGRAPHICAL DETAILS OF DIRECTORS AND SENIOR MANAGEMENT23 DIRECTORS’ REPORT30 CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME70 CONSOLIDATED STATEMENT OF CHANGES IN EQUITY74 CONSOLIDATED STATEMENT OF CASH FLOWS76 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS79 FINANCIAL SUMMARY EXECUTIVE DIRECTORS Mr. Wang Li Feng(Vice-Chairman)Mr. Fan XiaolingMr. Ni Xian (appointed on 4 March 2022)Dr. Chen Xiaofeng (appointed on 17 February 2022 andresigned on 29 December 2022)Mr. Yu Sanlong (resigned on 29 December 2022) Ms. Lee Jui-lan (resigned on 6 May 2022)Mr. Su Guang(Chief executive) (appointed on 1 May 2022and resigned on 29 December 2022) NON-EXECUTIVE DIRECTOR Mr. Huang Bin(Chairman) (appointed on 20 February 2022) INDEPENDENT NON-EXECUTIVE DIRECTORS Dr. Yan Ka ShingMr. Sui Fuxiang (appointed on 17 August 2022)Dr. Fong Chi Wai, Alex (resigned on 17 August 2022)Dr. Feng Shen (ceased on 4 March 2022)Mr. Wu Lebin (appointed on 20 February 2022)Mr. Xu Lin (appointed on 4 March 2022 andresigned on 29 December 2022) COMPANY SECRETARY Mr. Man Yun Wah (resigned on 8 April 2022)Mr. Tam Sik Wai (appointed on 8 April 2022 andresigned on 14 November 2022)Mr. Tsang Shiao Tung, Joseph(appointed on 14 November 2022) AUTHORISED REPRESENTATIVES Mr. Wang Li FengMr. Tam Sik Wai (appointed on 8 April 2022and resigned on 14 November 2022)Mr. Tsang Shiao Tung, Joseph (appointedon 14 November 2022) COMPLIANCE OFFICER Mr. Wang Li Feng Corporate Information AUDIT COMMITTEE Dr. Yan Ka Shing(Chairman)Mr. Sui Fuxiang (appointed on 17 August 2022)Dr. Feng Shen (ceased on 4 March 2022)Mr. Xu Lin (appointed on 4 March 2022 andresigned on 29 December 2022)Dr. Fong Chi Wai, Alex (resigned on 17 August 2022) REMUNERATION COMMITTEE Dr. Yan Ka Shing(Chairman)Mr. Sui Fuxiang (appointed on 17 August 2022)Mr. Wang Li FengDr. Feng Shen (ceased on 4 March 2022)Dr. Fong Chi Wai, Alex (appointed on 4 March 2022 andresigned on 17 August 2022) NOMINATION COMMITTEE Mr. Wang Li FengMr. Huang Bin(Chairman) (appointed on 4 March 2022) Dr. Yan Ka ShingMr. Sui Fuxiang (appointed on 17 August 2022)Dr. Feng Shen (ceased on 4 March 2022)Dr. Fong Chi Wai, Alex (appointed on 4 March 2022 andresigned on 17 August 2022)Mr. Xu Lin (appointed on 4 March 2022 and resignedon 29 December 2022) EXECUTIVE COMMITTEE Mr. Wang Li Feng(Chairman)Mr. Fan XiaolingDr. Yan Ka ShingMr. Sui Fuxiang (appointed on 17 August 2022)Ms. Lee Jui-lan (resigned on 6 May 2022)Mr. Yu Sanlong (resigned on 29 December 2022) Dr. Feng Shen (ceased on 4 March 2022)Dr. Fong Chi Wai, Alex (appointed on 4 March 2022 andresigned on 17 August 2022) STRATEGY AND DEVELOPMENT COMMITTEE Mr. Wang Li Feng(Chairman)Dr. Yan Ka ShingMr. Sui Fuxiang (appointed on 17 August 2022)Dr. Feng Shen (ceased on 4 March 2022)Dr. Fong Chi Wai, Alex (appointed on 4 March 2022and resigned on 17 August 2022) REGISTERED OFFICE Clarendon House2 Church StreetHamilton HM 11Bermuda Clarendon House2 Chu